Therapeutic Effect of Chrysin on Adenine-Induced Chronic Kidney Disease in Rats

Cellular Physiology and Biochemistry

Volumn 38, Issue 1, 2016, Pages 248-257

  Ali, Badreldin H ^a   Al Za''Abi, Mohammed ^a   Adham, Sirin A ^a   Yasin, Javed ^b   Nemmar, Abderrahim ^b   Schupp, Nicole ^c  

^a SULTAN QABOOS UNIVERSITY   (Oman)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Adenine; Chronic kidney disease; Chrysin; Inflammation; Oxidative damage; Rat

Indexed keywords

ADENINE; BIOLOGICAL MARKER; CATALASE; CHRYSIN; CYTOKINE; GLUTATHIONE; INDICAN; N ACETYL BETA GLUCOSAMINIDASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SUPEROXIDE DISMUTASE; ACUTE PHASE PROTEIN; ANTIOXIDANT; CREATININE; FLAVONOID; LIPOCALIN; NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN PROTEIN, RAT; ONCOPROTEIN; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC KIDNEY DISEASE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CREATININE BLOOD LEVEL; HISTOPATHOLOGY; INFLAMMATION; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY STRUCTURE; NONHUMAN; PRIORITY JOURNAL; RAT; THERAPY EFFECT; UREA BLOOD LEVEL; URINALYSIS; ANIMAL; BLOOD; CHEMICALLY INDUCED; CHEMISTRY; DISEASE MODEL; KIDNEY; METABOLISM; ORAL DRUG ADMINISTRATION; PATHOLOGY; RENAL INSUFFICIENCY, CHRONIC; URINE;

ACUTE-PHASE PROTEINS; ADENINE; ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; BIOMARKERS; CATALASE; CREATININE; CYTOKINES; DISEASE MODELS, ANIMAL; FLAVONOIDS; GLUTATHIONE; KIDNEY; LIPOCALINS; PROTO-ONCOGENE PROTEINS; RATS; RENAL INSUFFICIENCY, CHRONIC; SUPEROXIDE DISMUTASE; UREA;

EID: 84955576807     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000438626     Document Type: Article

References (29)

1. Kok HM, Falke LL, Goldschmeding R, Nguyen TQ: Targeting CTGF, EGF and PDGF pathways to prevent progression of kidney disease. Nat Rev Nephro 2014;10:700-711.
2. Stack AG, Casserly LF, Cronin CJ, Chernenko T, Cullen W, Hannigan A, Saran R, Johnson H, Browne G, Ferguson JP: Prevalence and variation of Chronic Kidney Disease in the Irish Health System: initial findings from the National Kidney Disease Surveillance Programme. BMC Nephrol 2014;15:185.
3. Cantaluppi V, Quercia AD, Dellepiane S, Ferrario S, Camussi G, Biancone L: Interaction between systemic inflammation and renal tubular epithelial cells. Nephrol Dial Transplant 2014;29:2004-2011.
4. Rubattu S, Mennuni S, Testa M, Mennuni M, Pierelli G, Pagliaro B, Gabriele E, Coluccia R, Autore C, Volpe M: Pathogenesis of chronic cardiorenal syndrome: is there a role for oxidative stress? Int J Mol Sci 2013;14:23011-2332.
5. Ali BH, Al-Salam S, Al Husseni I, Kayed RR, Al-Masroori N, Al-Harthi T, Al Zaabi M, Nemmar A: Effects of Gum Arabic in rats with adenine-induced chronic renal failure. Exp Biol Med (Maywood) 2010; 235:373-382.
6. Almquist T, Jacobson SH, Mobarrez F, Näsman P, Hjemdahl P: Lipid-lowering treatment and inflammatory mediators in diabetes and chronic kidney disease. Eur J Clin Invest 2014;44:276-284.
7. Ahad A, Ganai AA, Mujeeb M, Siddiqui WA: Chrysin, an anti-inflammatory molecule, abrogates renal dysfunction in type 2 diabetic rats. Toxicol Appl Pharmacol 2014;15:279:1-7.
8. Rehman MU, Ali N, Rashid S, Jain T, Nafees S, Tahir M, Khan AQ, Lateef A, Khan R, Hamiza OO, Kazim S, Qamar W, Sultana S: Alleviation of hepatic injury by chrysin in cisplatin administered rats: Probable role of oxidative and inflammatory markers. Pharmacol Rep 2014;66:1050-1059.
9. Bae Y, Lee S, Kim SH: Chrysin suppresses mast cell-mediated allergic inflammation: involvement of calcium, caspase-1 and nuclear factor-κB. Toxicol Appl Pharmacol 2011;254:56-64.
10. Cherkaoui-Tangi K, Lachkar M, Wibo M, Morel N, Gilani AH, Lyoussi B: Pharmacological studies on hypotensive, diuretic and vasodilator activities of chrysin glucoside from Calycotome villosa in rats. Phytother Res 2008;22:356-361.
11. Rashid S, Ali N, Nafees S, Ahmad ST, Arjumand W, Hasan SK, Sultana S: Alleviation of doxorubicin-induced nephrotoxicity and hepatotoxicity by chrysin in Wistar rats. Toxicol Mech Methods 2013;23:337-345.
12. Anand KV, Anandhi R, Pakkiyaraj M, Geraldine P: Protective effect of chrysin on carbon tetrachloride (CCl4)-induced tissue injury in male Wistar rats. Toxicol Ind Health 2011;27:923-933.
13. Ali BH, Adham SA, Al Za'abi M, Waly MI, Yasin J, Nemmar A, Schupp N: Ameliorative effect of chrysin on adenine-induced chronic kidney disease in rats. PLoS One 2015;24:e0125285.
14. Ikeda R, Imai Y, Maruyama W, Mizoguchi K: Systemic disorders of calcium dynamics in rats with adenineinduced renal failure: implication for chronic kidney disease-related complications. Nephrology (Carlton) 2010;15:54-62.
15. Al Za'abi M, Al Busaidi M, Yasin J, Schupp N, Nemmar A, Ali BH: Development of a new model for the induction of chronic kidney disease via intraperitoneal adenine administration, and the effect of treatment with gum acacia thereon. Am J Transl Res 2015;7:28-38.
16. Ali BH, Inuwa I, Al Za'abi M, Al Bahlani S, Al Issaei H, Ramkumar A, Madanagopal T, Nemmar A, Malheiros DM, Zatz R: Renal and myocardial histopathology and morphometry in rats with adenine-induced chronic renal failure: influence of gum acacia. Cell Physiol Biochem. 2014;34:818-828.
17. Leopoldini M, Russo N, Toscano M: The molecular basis of working mechanism of natural polyphenolic antioxidants. Food Chem 2011;125:288-306.
18. Sirovina D, Orsolić N, Koncić MZ, Kovacević G, Benković V, Gregorović G: Quercetin vs chrysin: effect on liver histopathology in diabetic mice. Hum Exp Toxicol 2013;32:1058-1066.
19. Tahir M, Sultana S: Chrysin modulates ethanol metabolism in Wistar rats: A promising role against organ toxicities. Alcohol Alcohol 2011;46:383-392.
20. Ali BH, Alza'abi M, Ramkumar A, Al-Lawati I, Waly MI, Beegam S, Nemmar A, Brand S, Schupp N: The effect of activated charcoal on adenine-induced chronic renal failure in rats. Food Chem Toxicol 2014;65:321-328.
21. Kobayashi T, Matsumura Y, Ozawa T, Yanai H, Iwasawa A, Kamachi T, Fujiwara K, Tanaka N, Kohno M: Exploration of novel predictive markers in rat plasma of the early stages of chronic renal failure. Anal Bioanal Chem 2014;406:1365-1376.
22. Watanabe H: Molecular mechanisms for uremic toxin-induced oxidative tissue damage via a cardiovascular-renal connection. Yakugaku Zasshi 2013;133:889-895.
23. Ali BH, Al-Salam S, Al Za'abi M, Waly MI, Ramkumar A, Beegam S, Al-Lawati I, Adham SA, Nemmar A: New model for adenine-induced chronic renal failure in mice, and the effect of gum acacia treatment thereon: comparison with rats. J Pharmacol Toxicol Methods 2013;68:384-393.
24. Ali BH, Al-Salam S, Al Za'abi M, Al Balushi KA, Ramkumar A, Waly MI, Yasin J, Adham SA. Nemmar A: Does swimming exercise affect experimental chronic kidneydisease in rats treated with gum acacia? PLoS One 2014;9:e102528.
25. García-García PM, Getino-Melián MA, Domínguez-Pimentel V, Navarro-González JF: Inflammation in diabetic kidney disease. World J Diabetes 2014;5:431-443.
26. Yao Y, Chen L, Xiao J, Wang C, Jiang W, Zhang R, Hao J: Chrysin protects against focal cerebral ischemia/ reperfusion injury in mice through attenuation of oxidative stress and inflammation. Int J Mol Sci 2014;15:20913-20926.
27. Gonçalves FL, Elias RM, Dos Reis LM, Graciolli FG, Zampieri FG, Oliveira RB, Jorgetti V, Moysés RM: Serum sclerostin is an independent predictor of mortality in hemodialysis patients. BMC Nephrol 2014;151:190.
28. Drechsler C, Evenepoel P, Vervloet MG, Wanner C, Ketteler M, Marx N, Floege J, Dekker FW, Brandenburg VM, NECOSAD Study Group: High levels of circulating sclerostin are associated with better cardiovascular survival in incident dialysis patients: results from the NECOSAD study. Nephrol Dial Transplant 2014;30:288-293.
29. Okada H, Kaneko Y, Yawata T, Uyama H, Ozono S, Motomiya Y, Hirao Y: Reversibility of adenine-induced renal failure in rats. Clin Exp Nephrol 1999;3:82-88.